A randomized phase II study of gemcitabine (G) vs gemcitabine/carboplatin (GC) as consolidation therapy to concurrent chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC): A Lung Cancer Research Group (LCRG) study
In: Journal of Clinical Oncology, Jg. 26 (2008-05-20), S. 7559-7559
Online
unknown
Zugriff:
7559 Background: Consolidation chemotherapy following concurrent CRT may improve systemic control and possibly prolong survival of pt with stage III NSCLC. Phase II study using docetaxel showed pro...
Titel: |
A randomized phase II study of gemcitabine (G) vs gemcitabine/carboplatin (GC) as consolidation therapy to concurrent chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC): A Lung Cancer Research Group (LCRG) study
|
---|---|
Autor/in / Beteiligte Person: | Lam, K. ; Lee, J. ; Zhou, C. ; Zhang, L. ; Liao, M. ; Wu, Y. ; Mok, Tony ; Boyer, Michael ; Lu, S. ; Yang, C. |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 26 (2008-05-20), S. 7559-7559 |
Veröffentlichung: | American Society of Clinical Oncology (ASCO), 2008 |
Medientyp: | unknown |
ISSN: | 1527-7755 (print) ; 0732-183X (print) |
DOI: | 10.1200/jco.2008.26.15_suppl.7559 |
Schlagwort: |
|
Sonstiges: |
|